TaBlitz Labs
TaBlitz Labs is a U.S. pharmaceutical technology company offering AI-driven tablet formulation development, powder characterization, and scale-up services to pharmaceutical, nutraceutical, and animal health organizations, alongside technology licensing to CDMOs and CMOs.
- Company typePrivate
- Founded2023
- HeadquartersSt Louis, United States
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What TaBlitz Labs does
TaBlitz Labs is a U.S.-based pharmaceutical technology company founded in 2023 and headquartered in St. Louis. It operates as an "AI CDMO partner," providing formulation development, analytical, and material characterization services to pharmaceutical, nutraceutical, and animal health organizations. The company serves two customer tracks: end-user organizations seeking preformulation through scale-up formulation support, and contract development and manufacturing organizations (CDMOs/CMOs) that license the company's technology to deliver AI-driven tablet development capabilities to their own clients.
The company's core technology comprises two components: TaBlitz AI, a deep learning engine applied to tablet design and optimization that delivers data-driven recommendations for manufacturability, tool life, and performance; and the TaBlitz Platform for particle and tablet analytics, built on powder characterization practice aligned with USP <1062> and Pharmeuropa 5.44. These are complemented by Formulation and Development Services including preformulation, formulation development, and troubleshooting grounded in rigorous powder characterization. Revenue is generated through two streams: professional services engagements and technology licensing/implementation for CDMOs and CMOs. Pricing is not publicly disclosed and follows a contact-sales model. The go-to-market motion is sales-led, supported by participation in specialist training programs and the Compaction Simulation Forum, direct enterprise outreach, and a website displaying an enterprise customer logo lineup spanning Pfizer, Vertex Pharmaceuticals, Zentiva, Catalent, Haleon, Alkaloid Pharmaceuticals, Pharma Nord, Takeda, and Elanco.
TaBlitz Labs firmographics
Firmographics- Name
- TaBlitz Labs
- Legal name
- TaBlitz Labs
- Website
- https://tablitz.us
- Company type
- Private
- Founded year
- 2023
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- TaBlitz Labs is a U.S. pharmaceutical technology company offering AI-driven tablet formulation development, powder characterization, and scale-up services to pharmaceutical, nutraceutical, and animal health organizations, alongside technology licensing to CDMOs and CMOs.
- Ownership category
- akta.pro rank
TaBlitz Labs industry classification
Industry- Product category
- Pharmaceutical Formulation Technology
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541), Analytical Laboratory Instrument Manufacturing (334516), Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731), Pharmaceutical Preparations (2834), Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO (HLAGABAB)
- akta.pro secondary industries
- AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO), CMC & Pharmaceutical Development (Formulation/Process/Analytical Development) (HLAIALAD), Contract Development & Manufacturing for Generics (CDMO/CMO) (HLAIABAI)
Keywords
Where TaBlitz Labs is headquartered
LocationHeadquarters
- HQ city
- St Louis
- HQ country
- United States
- HQ region
- North America
Markets served
TaBlitz Labs business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- Formulation and Development Services: Preformulation, formulation development, and troubleshooting services grounded in rigorous powder characterization and aligned with regulatory expectations, targeting organizations seeking formulation support and development services.
- Technology Licensing and Implementation: Technology implementation services for CDMOs and CMOs who want to implement TaBlitz technology to offer the full TaBlitz advantage to their own clients, including platform access and AI capabilities.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
TaBlitz Labs product offering
Product offeringCore offering
TaBlitz Labs operates as an AI CDMO partner delivering formulation development services alongside a proprietary software platform (TaBlitz AI and TaBlitz Platform) for tablet and powder characterization. The company combines deep learning, formulation science, and mechanical principles to help pharmaceutical and nutraceutical organizations accelerate tablet development, reduce scale-up risk, and align with regulatory references including USP <1062> and Pharmeuropa 5.44. Revenue is generated through formulation/development services, technology licensing and implementation, and equipment sales/instrument partnerships.
Product overview
TaBlitz Labs offers a unified platform architecture centered on the TaBlitz AI engine and TaBlitz Platform for particle and tablet analytics. TaBlitz AI applies deep learning to tablet design and optimization, delivering data-driven recommendations for manufacturability, tool life, and performance. The TaBlitz Platform supports particle and tablet analytics built on powder characterization practice aligned with USP <1062> and Pharmeuropa 5.44. These technology offerings are complemented by Formulation & Development Services covering preformulation through scale-up.
Differentiator
Problem solved
Functional benefit
Products and services
- TaBlitz AI Proprietary deep-learning model that supports tablet and powder formulation development for pharmaceutical, nutraceutical, and CDMO organizations.
- TaBlitz Platform Software platform for automated tablet and powder characterization, designed to integrate with laboratory instruments and align with regulatory references such as USP <1062> and Pharmeuropa 5.44.
- Formulation and Development Services Professional formulation and development services delivered by TaBlitz Labs as an AI CDMO partner, leveraging TaBlitz AI and the TaBlitz Platform to accelerate tablet development and reduce scale-up risk.
Quantifiable outcome
- Reduces development time through holistic, science-driven approaches and comprehensive characterization
- +1 more outcomes
Companies that use TaBlitz Labs
Customer profileNamed customers9 records
Segments3 records
Ideal customer profiles3 records
TaBlitz Labs technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature3 records
TaBlitz Labs partnerships and signals
Strategic signalRecent moves5 records
Expansion highlights4 records
TaBlitz Labs competitors and assessment
Company assessmentBroad incumbents
- Certara: Certara provides modeling, simulation, and regulatory science software for pharmaceutical R&D. Comparable to TaBlitz as a software/AI vendor serving pharmaceutical development and regulatory workflows across the development lifecycle.
- Malvern Panalytical: Malvern Panalytical supplies particle characterization and analytical instruments used in pharmaceutical powder and tablet analysis. Comparable to TaBlitz as a technology provider serving pharmaceutical powder characterization and formulation analytics.
- Patheon (Thermo Fisher Scientific): Patheon, now part of Thermo Fisher, is a global CDMO offering pharmaceutical development and commercial manufacturing services including OSD formulation. Comparable to TaBlitz as a CDMO competitor in formulation development, though at vastly larger scale and broader service portfolio.
Emerging players
- Firmenich (now dsm-firmenich): dsm-firmenich provides formulation and ingredient solutions for pharma and nutrition, including oral solid dose platforms. Comparable to TaBlitz in serving tablet/nutraceutical formulation development and scale-up, with overlap in the nutraceutical customer segment.
Direct peers
- Simulations Plus: Simulations Plus provides modeling and simulation software for pharmaceutical R&D, including formulation and ADMET prediction. Comparable to TaBlitz as an AI/software vendor serving pharmaceutical formulation, development, and regulatory workflows.
- Schrödinger: Schrödinger provides AI-driven physics-based molecular simulation and materials informatics platforms for pharmaceutical R&D. Comparable to TaBlitz in applying AI/ML to pharmaceutical development workflows, though Schrödinger focuses on molecular design while TaBlitz targets formulation and tablet design.
- Alcami Corporation: Alcami is a CDMO offering drug development, formulation, and analytical services across small and large molecules. Comparable to TaBlitz as a CDMO peer with formulation development and analytical characterization capabilities.
- Cambrex: Cambrex is a CDMO providing API development, formulation, and analytical services for small molecule pharmaceuticals. Comparable to TaBlitz in pharmaceutical development services for OSD formulation and characterization.
- Quotient Sciences: Quotient Sciences is a formulation development and CDMO focused on oral solid dose and integrated drug development services. Comparable to TaBlitz in the formulation development and scale-up support market for pharma clients.
Regional players
- FREUND-VECTOR: FREUND-VECTOR manufactures compaction simulation equipment and granulation technology used in tablet development and scale-up. Comparable to TaBlitz in serving the tablet formulation and compaction development workflow, though as a hardware/equipment provider rather than AI software.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
TaBlitz Labs social profiles
Digital presenceTaBlitz Labs financial estimates
Financial estimateRevenue estimate
Valuation estimate
TaBlitz Labs leadership team
Management profileNumber of profiles
TaBlitz Labs funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
TaBlitz Labs M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about TaBlitz Labs
What does TaBlitz Labs do?
TaBlitz Labs operates as an AI CDMO partner delivering formulation development services alongside a proprietary software platform (TaBlitz AI and TaBlitz Platform) for tablet and powder characterization. The company combines deep learning, formulation science, and mechanical principles to help pharmaceutical and nutraceutical organizations accelerate tablet development, reduce scale-up risk, and align with regulatory references including USP <1062> and Pharmeuropa 5.44. Revenue is generated through formulation/development services, technology licensing and implementation, and equipment sales/instrument partnerships.
Is TaBlitz Labs a public or private company?
TaBlitz Labs is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was TaBlitz Labs founded?
TaBlitz Labs was founded in 2023. It employs 1 to 10 people.
Where is TaBlitz Labs based?
TaBlitz Labs is headquartered in St Louis, United States, in the North America region.
How does TaBlitz Labs make money?
Two revenue lines are on record. Formulation and Development Services are the primary driver. The others are technology Licensing and Implementation.
Who are TaBlitz Labs's main competitors?
Broad incumbents on record are Certara, Malvern Panalytical and Patheon (Thermo Fisher Scientific). Firmenich (now dsm-firmenich) is listed as an emerging player. Direct peers are Simulations Plus, Schrödinger, Alcami Corporation, Cambrex and Quotient Sciences. FREUND-VECTOR is listed as a regional player.
Does TaBlitz Labs have an API?
No public API is recorded for TaBlitz Labs.
What industry is TaBlitz Labs in?
TaBlitz Labs's product category is Pharmaceutical Formulation Technology. Its primary akta.pro industry code is HLAGABAB, Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO, with a secondary code of HLAGAJAO, AI/ML Platforms for Drug Discovery & Experiment Optimization. Its NAICS code is 325412 and its SIC code is 8731.